The FDA has approved the first pill version of Wegovy, expanding access to one of the most popular and effective weight-loss ...
The FDA approved Novo Nordisk’s once-daily Wegovy pill, making it the first oral GLP-1 weight loss drug to reach the U.S.
Ionis Pharmaceuticals IONS announced that the FDA has granted the Breakthrough Therapy designation to its pipeline candidate, ION582, for the treatment of Angelman syndrome (AS), a rare neurological ...
Zacks Investment Research on MSN
AZN, Daiichi's Enhertu gets breakthrough tag for expanded cancer use
AstraZeneca AZN and its Japan-based partner Daiichi Sankyo announced that the FDA has granted a Breakthrough Therapy ...
Merck (MRK) and its Japanese partner Daiichi Sankyo announced that the FDA has granted Breakthrough Therapy Designation ("BTD") to their investigational pipeline candidate, raludotatug deruxtecan ...
The arrival of GLP-1 medications like Ozempic® and Wegovy® has been nothing short of revolutionary for weight loss and diabetes management. These drugs, which include active ingredients like ...
On Friday, the FDA cleared zoliflodacin, a one-dose pill, after a large clinical trial showed it was safe and effective. Results from that trial were published Dec. 11 in the jour ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback